Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,090,698
+$1,952,926 QoQ
Shares Held
58,225
+20.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#448
of 2,105 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026&PARTNERS holds $76,040,383 across 16 Diagnostics & Research names. DHR ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
124,363 | $26,358,737 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
28,690 | $14,384,018 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
58,225 | $11,090,698 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
6,313 | $3,323,415 | |
| 5 | WAT |
Waters Corp /De/
|
8,275 | $3,103,456 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,611 | $2,971,080 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,309 | $2,764,784 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,426 | $2,343,965 |
All Filings in DHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,090,698 | 58,225 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,137,772 | 48,195 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,630,970 | 37,703 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,144,870 | 30,994 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,229,278 | 26,472 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,186,295 | 25,299 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,351,958 | 23,315 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,990,143 | 14,352 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,256,495 | 5,029 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||